CHF75.30
1.07%
SIX Swiss Exchange, Apr 17, 05:31 pm CET
ISIN
CH0386200239
Symbol
MED
Sector

Medartis Stock price

CHF75.30
+4.80 6.81% 1M
+18.60 32.80% 6M
+18.70 33.04% YTD
-5.90 7.27% 1Y
-40.10 34.75% 3Y
+36.20 92.58% 5Y
+13.34 21.53% 10Y
SIX Swiss Exchange, Closing price Thu, Apr 17 2025
+0.80 1.07%
ISIN
CH0386200239
Symbol
MED
Sector

Key metrics

Market capitalization CHF933.42m
Enterprise Value CHF915.96m
P/E (TTM) P/E ratio 281.29
EV/FCF (TTM) EV/FCF 43.62
EV/Sales (TTM) EV/Sales 4.07
P/S ratio (TTM) P/S ratio 4.15
P/B ratio (TTM) P/B ratio 3.46
Revenue growth (TTM) Revenue growth 6.05%
Revenue (TTM) Revenue CHF224.83m
EBIT (operating result TTM) EBIT CHF-4.93m
Free Cash Flow (TTM) Free Cash Flow CHF21.00m
EPS (TTM) EPS CHF0.27
P/E forward 61.12
P/S forward 3.48
EV/Sales forward 3.42
Show more

Is Medartis a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

Medartis Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Medartis forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a Medartis forecast:

Buy
80%
Hold
20%

Financial data from Medartis

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Dec '24
+/-
%
225 225
6% 6%
100%
- Direct Costs 46 46
4% 4%
21%
179 179
7% 7%
79%
- Selling and Administrative Expenses 118 118
8% 8%
53%
- Research and Development Expense 43 43
66% 66%
19%
17 17
46% 46%
8%
- Depreciation and Amortization 22 22
6% 6%
10%
EBIT (Operating Income) EBIT -4.93 -4.93
143% 143%
-2%
Net Profit 3.53 3.53
469% 469%
2%

In millions CHF.

Don't miss a Thing! We will send you all news about Medartis directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Medartis Stock News

AD HOC NEWS
about one month ago
Medartis Holding AG / CH0386200239

Company Profile

Medartis Holding AG engages in the development, manufacture, and sale of medical devices for surgical fixation of bone fractures. It operates through the following geographical segments: EMEA, US, APAC, and LATAM. The company was founded by Thomas Straumann on November 3, 1997 and is headquartered in Basel, Switzerland.

Head office Switzerland
CEO Matthias Schupp
Employees 949
Founded 1997
Website www.medartis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today